These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7055936)

  • 1. Characterization of uremic "middle molecular" fractions by gas chromatography, mass spectrometry, isotachophoresis, and liquid chromatography.
    Schoots AC; Mikkers FE; Claessens HA; De Smet R; Van Landschoot N; Ringoir SM
    Clin Chem; 1982 Jan; 28(1):45-9. PubMed ID: 7055936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bound amino acids in uremic sera: search for peptidic middle molecules by preparative polyacrylamide gel electrophoresis and high performance liquid chromatography.
    Kaplan B; Gotfried M; Cojocaru M; Pras M; Ravid M
    Clin Chim Acta; 1989 Nov; 185(2):119-30. PubMed ID: 2624993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation of six uremic middle molecular compounds by high performance liquid chromatography and analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chu J; Yuan Z; Liu X; Wu Q; Mi H; He B
    Clin Chim Acta; 2001 Sep; 311(2):95-107. PubMed ID: 11566169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of uremic ultrafiltrate using high resolution gas chromatography-mass spectrometry - identification of 6 polyphenols.
    Niwa T; Maeda K; Ohki T; Saito A; Kobayashi S; Asada H; Kobayashi K
    Clin Chim Acta; 1980 Nov; 108(1):113-9. PubMed ID: 7449132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of endogenous middle molecules in normal and uremic body fluids.
    Fürst P; Zimmerman L; Bergström J
    Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L; Dall'taglio P; Buzio C
    Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical ionization mass spectrometry of trimethylsilylated carbohydrates and organic acids retained in uremic serum.
    Schoots AC; Leclercq PA
    Biomed Mass Spectrom; 1979 Nov; 6(11):502-7. PubMed ID: 534687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G; Chu J; Liu X; Yuan Z
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
    Le Moel G; Strecker G; Cueille G; Boudet J; Man NK; Galli A; Agneray J
    Artif Organs; 1981; 4 Suppl():17-21. PubMed ID: 7295087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremic ultrafiltrate inhibits platelet-activating factor synthesis.
    Wratten ML; Tetta C; De Smet R; Neri R; Sereni L; Camussi G; Vanholder R
    Blood Purif; 1999; 17(2-3):134-41. PubMed ID: 10449871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular weight distribution, diffusibility and comparability of middle molecular fractions prepared from normal and uremic sera by different fractionation procedures.
    Gróf J; Menyhárt J
    Nephron; 1982; 30(1):60-7. PubMed ID: 7088233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance.
    Gallice P; Monti JP; Crevat A; Durand C; Murisasco A
    Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism.
    Hsu CH; Vanholder R; Patel S; De Smet RR; Sandra P; Ringoir SM
    Kidney Int; 1991 Nov; 40(5):868-73. PubMed ID: 1762291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and quantification of a protein-bound ligand in uremic serum.
    Takeda N; Niwa T; Tatematsu A; Suzuki M
    Clin Chem; 1987 May; 33(5):682-5. PubMed ID: 3568353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study by means of high-performance liquid chromatography of solutes that decrease theophylline/protein binding in the serum of uremic patients.
    De Smet R; Vogeleere P; Van Kaer J; Lameire N; Vanholder R
    J Chromatogr A; 1999 Jun; 847(1-2):141-53. PubMed ID: 10431358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPLC study of uremic fluids related to optical dialysis adequacy monitoring.
    Lauri K; Tanner R; Jerotskaja J; Luman M; Fridolin I
    Int J Artif Organs; 2010 Feb; 33(2):96-104. PubMed ID: 20306436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry in the search for uremic toxins.
    Niwa T
    Mass Spectrom Rev; 1997; 16(6):307-32. PubMed ID: 9703693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat.
    Anderstam B; Mamoun AH; Södersten P; Bergström J
    J Am Soc Nephrol; 1996 Nov; 7(11):2453-60. PubMed ID: 8959639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
    Popławski A; Myśliwiec M
    Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Middle molecules separation from uraemic serum (author's transl)].
    Dall'aglio P; Buzio C; Gardini GP; Migone L
    Ateneo Parmense Acta Biomed; 1975; 46(5):331-44. PubMed ID: 1236694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.